SLN fundamentals
Silence Therapeutics Plc - American Depository Share financial statements, including revenue, expenses, and profit
The total revenue of SLN for the last quarter is 1.48 M USD, and it's 96.76% higher compared to the previous quarter. The net income of Q3 24 is -35.12 M USD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM